Lexicon Forms Development and Financing Agreement with Symphony Capital
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 85 (Table of Contents)
Published: 7 Jul-2007
DOI: 10.3833/pdr.v2007.i85.314 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Lexicon entered into development agreement with Symphony Capital Partners to move Lexicon’s drug candidates - LX1671 in phase 2b clinical trials for treating cognitive disorders, LX1031 in phase 1b clinical trials for treating irritable bowel syndrome and LX1032 in preclinical stage for treating gastrointestinal disorders into advanced clinical development...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS